Edwards Lifesciences Corporation (EW)
NYSE: EW · IEX Real-Time Price · USD
85.94
-0.51 (-0.59%)
At close: Apr 19, 2024, 4:00 PM
86.00
+0.06 (0.07%)
After-hours: Apr 19, 2024, 7:02 PM EDT

Edwards Lifesciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1997
Net Income
1,4021,5221,503823.41,047722.2583.6569.5494.9811.1
Upgrade
Depreciation & Amortization
173.1166.8163.3135.4114.677.481.971.265.868.6
Upgrade
Share-Based Compensation
139.4126.8109.392.681.37161.656.949.948.3
Upgrade
Other Operating Activities
-819.1-597.3-43.62.9-59.956.1273.66.8-60.994.3
Upgrade
Operating Cash Flow
895.81,2181,7321,0541,183926.71,001704.4549.71,022
Upgrade
Operating Cash Flow Growth
-26.47%-29.67%64.29%-10.87%27.65%-7.39%42.06%28.14%-46.23%116.27%
Upgrade
Capital Expenditures
-253-244.6-325.8-407-254.4-238.7-168.1-176.1-102.7-79.8
Upgrade
Acquisitions
-125.2-109.6-13.1-10-135.20-192.9-5.7-333.7-24.1
Upgrade
Change in Investments
577.8655.5-1,335.2-101.7-171.1341.4-231.310.2121.7-518.3
Upgrade
Other Investing Activities
-25.8-49-48.4-12.4-35.1-26-54.9-40.1-1.4-10.8
Upgrade
Investing Cash Flow
173.8252.3-1,722.5-531.1-595.876.7-647.2-211.7-316.1-633
Upgrade
Share Issuance / Repurchase
-709.7-1,580.7-354.2-484.9-102.8-648.5-649.5-559-192.9-187.6
Upgrade
Debt Issued / Paid
-0.3-0.2-1.8-0.8-10-437.3176.3222.11.9-12.7
Upgrade
Other Financing Activities
-1-3.6-0.3-1.2-2.8-15.4-68.432.447.3
Upgrade
Financing Cash Flow
-711-1,584.5-356.3-486.9-115.6-1,101.2-473.2-268.5-158.6-153
Upgrade
Exchange Rate Effect
16.819.213.9-20.5-3-6.57.9-12.5-10.4-2.9
Upgrade
Net Cash Flow
375.4-94.8-332.815.8468.5-104.3-111.8211.764.6233.4
Upgrade
Free Cash Flow
642.8973.61,406647.3928.5688832.6528.3447942.5
Upgrade
Free Cash Flow Growth
-33.98%-30.77%117.26%-30.29%34.96%-17.37%57.60%18.19%-52.57%157.51%
Upgrade
Free Cash Flow Margin
10.70%18.09%26.88%14.76%21.35%18.48%24.24%17.83%17.93%40.57%
Upgrade
Free Cash Flow Per Share
1.061.572.261.041.491.101.320.830.691.48
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).